tm logo
LUMINA
Live/Registered
REGISTERED

on 07 May 2024

Last Applicant/ Owned by

101 West Dickman St., Ste 900

Baltimore

MD

21230

Serial Number

88329689 filed on 07th Mar 2019

Registration Number

7380903 registered on 07th May 2024

in the Principal Register

Correspondent Address

JOSHUA M DALTON

JOSHUA M DALTON MORGAN LEWIS & BOCKIUS LLP

BOSTON, MA 02110

UNITED STATES

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

LUMINA

Injectable hyaluronic acid dermal filler for medical, surgical or post-surgical, or clinical use; injectable dermal filler for use in augmentation of soft tissue for cosmetic use; injectable dermal filler for use in treatment of facial lines and wrinkles; none of the foregoing being drug delivery embolization apparatus or instruments

Classification Information


Class [005]
Pharmaceutical Products


Injectable hyaluronic acid dermal filler for medical, surgical or post-surgical, or clinical use; injectable dermal filler for use in augmentation of soft tissue for cosmetic use; injectable dermal filler for use in treatment of facial lines and wrinkles; none of the foregoing being drug delivery embolization apparatus or instruments


First Use Date in General

18th Dec 2020

First Use Date in Commerce

18th Dec 2020

Mark Details


Serial Number

No 88329689

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
07th May 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
07th May 2024REGISTERED-PRINCIPAL REGISTER
05th Apr 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04th Apr 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04th Apr 2024STATEMENT OF USE PROCESSING COMPLETE
04th Apr 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
14th Mar 2024TEAS STATEMENT OF USE RECEIVED
14th Mar 2024USE AMENDMENT FILED
22nd Sep 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
21st Sep 2023SOU EXTENSION 5 GRANTED